12th Berlin Conference on Life Sciences: Novel Antimicrobials and AMR Diagnostics 2019
Berlin (Germany)
The Novel Antimicrobials and AMR Diagnostics 2019 conference is a platform for SMEs, start-ups, big pharma, academia, investors and governmental institutions to discuss strategies and the specific challenges faced by SMEs in bringing new antimicrobial treatments and diagnostics to the market.
WHAT YOU CAN EXPECT:
350+ attendees from 20+ countries
70+ high-level speakers discussing current AMR issues
Focus on human and animal health
Topics: Financing and funding | Start-up pitch | Clinical development and market access | Therapeutics and diagnostics | R&D trends
Policy forum, co-organised with WHO and UNCTAD
Pre-conference workshop on ‘Resistance testing – beyond serial pass experiments’, jointly supported by NOVO Repair Impact Fund, GARDP, CARB-X and Wellcome Trust
Poster session, exhibition and pre-scheduled one-to-one investor meetings
AMR NEWS
Your Biweekly Source for Global AMR Insights!
Stay informed with the essential newsletter that brings together all the latest One Health news on antimicrobial resistance. Delivered straight to your inbox every two weeks, AMR NEWS provides a curated selection of international insights, key publications, and the latest updates in the fight against AMR.
Don’t miss out on staying ahead in the global AMR movement—subscribe now!